MedCity News

Novo Nordisk Commits Up to $2B to Drug Delivery Startup Vivtex for R&D of Oral Metabolic Meds

Digital generated image of dollar sign lying on a medical couch visualizing crisis and loss.

AI-Driven Coding is Driving Costs Up. How Can Payers Adapt?

As AI-enabled coding increasingly adjudicates and reimburses claims on the first pass, often at higher levels, payers face a growing challenge: traditional cost-containment mechanisms are unable to keep pace.

By Liz Levy

Top-Rated Health Insurance Plans for Companies With Remote Employees

Remote work reshapes how companies recruit, retain and support talent, and benefits have to keep up.

By The Difference Card

MedCity Influencers

Making Quality a Daily Habit

Sustainable quality doesn’t live in binders or dashboards; it lives in the small, repeatable actions that happen every day.

By Deb Jones

Latest Video

Latest News

BioPharma, Artificial Intelligence

Valo Health CEO: We Don’t Want Investors To Drive the Science

Brian Alexander feels the current system of drug development is shaped by biotech investor expectations. Valo Health is eschewing that path.

By Arundhati Parmar

Artificial Intelligence, Startups, Health Tech, Providers

Man look at the dashboard with graphs and charts. Concept of data management system, business intelligence, data statistics, marketing analysis, key performance indicators (KPI) and analytics.

4 Health Tech Trends Startups Can’t Ignore, Per an Oak HC/FT Partner

During a recent interview at the ViVE conference in Los Angeles, Oak HC/FT Partner Vig Chandramouli shared four key trends shaping the health tech startup market, from underinvested labor management, pricing risks and the influence of Epic on long-term deals.

By Katie Adams

Health Tech

Coral Care Raises $13M to Scale In-Home Pediatric Therapy

Coral Care's Series A round was led by Haymaker Ventures, with participation from FCA Ventures, Peterson Ventures, Alleycorp, Reach Capital, Jefferson River Capital, Greymatter Capital, Mother Ventures and Charge Ventures.

By Marissa Plescia

Startups

Jet trail creating dollar sign in blue sky with clouds startup capital

Headache Startup Slate Medicines Lands $130M to Bring Novel Migraine Drug Into the Clinic

Slate Medicines’ antibody drug is designed to block PACAP, a protein associated with migraines. The Phase 1-ready asset was licensed from China-based DartsBio Pharmaceuticals.

By Frank Vinluan

MedCity Influencers

2026 Star Ratings Shift: 4 Strategies for MA Plans

Further change in the Star Ratings program is inevitable, but one thing won’t change: plans that make targeted investments in improving the member experience and clinical outcomes, driven by data, are the most likely to succeed and achieve a higher overall rating.

By Marge Ciancetta

MedCity Influencers

How AI Is Transforming Detection of Congenital Heart Defects

In prenatal cardiology, that clarity can mean earlier diagnoses, safer deliveries, and better supported families who are prepared for what lies ahead.

By Dr. Nathan S. Fox

Legal

DOJ, Ohio File Antitrust Suit Against OhioHealth Over Payer Contracts

The Department of Justice and the state of Ohio filed an antitrust lawsuit against OhioHealth this week, alleging the health system used “all-or-nothing” contracts that force insurers to include all of its hospitals and physicians. The case highlights federal and state scrutiny of hospital consolidation and restrictive contracting practices — with potential implications for payers, patients and healthcare markets across the country.

By Katie Adams

Health Tech

Care.com and Headspace Launch Mental Health Partnership for Caregivers

Headspace and Care.com partnered to provide caregivers with brief mindfulness content and free subscriptions to support their mental health.

By Marissa Plescia

BioPharma, Pharma

Gilead Sciences Is Acquiring Arcellx and Partnered Multiple Myeloma Drug in $7.8B Deal

Gilead Sciences and Arcellx have been collaborating on the multiple myeloma cell therapy anito-cel since 2022. This therapy was designed to provide better safety, which would be an advantage over Carvykti, the blockbuster multiple myeloma product marketed by Johnson & Johnson and Legend Biotech.

By Frank Vinluan

MedCity Influencers

Prior Authorization Is Broken. CMS’s New Rule Shows Why Regulated AI Is the Way Out

Technology alone won’t solve prior authorization. But refusing to adopt it guarantees the status quo: a system where insurers operate at machine speed, providers operate at human speed, and patients pay the price in delayed care.

By Jeffrey Morelli

MedCity Influencers

Why HealthTech Products Fail Clinical Deployment & How To Prevent It

Companies can avoid this trap by treating future growth as a foundation, not a later stage. Decision makers need to work backwards from scale, building software architecture and commercial architecture together. This shift alone helps teams make smarter choices within the first 90 days of a product’s launch.

By Sanket Patel

Health Tech, Hospitals, Providers

Wide shot rear view of grandmother walking with grandsons through front yard of home

The Rural Care Crisis Is an Economic Issue, Not Just a Public Health One

As hundreds of rural hospitals face the risk of closure, healthcare leaders warn that the fallout extends far beyond patient outcomes. During a panel at ViVE in Los Angeles, healthcare leaders outlined how access to care underpins the economic stability of rural America.

By Katie Adams

Health Tech

What Experts Say About Hims & Hers’ $1.15B Acquisition of Eucalyptus

Experts say Hims & Hers’ acquisition of Eucalyptus positions the company for global expansion and revenue diversification amid U.S. GLP-1 regulatory challenges.

By Marissa Plescia